CVS Gives Preferred Status to Gilead Hepatitis C Drugs Harvoni, Sovaldi zz - Stock版 - 未名存档

本页内容为未名空间相应帖子的节选和存档，一周内的贴子最多显示50字，超过一周显示500字访问原贴

Stock版 - CVS Gives Preferred Status to Gilead Hepatitis C Drugs Harvoni, Sovaldi zz

相关主题
● For GILD share holders or anyone of interest	● 200 威逼奖励对GILD的分析
● U.S. FDA approves AbbVie all-oral hepatitis C treatment	● GILD 4:30 ER
● U.S. FDA approves AbbVie all-oral hepatitis C treatment	● Gilead to raise price for new hepatitis C drug above $84,000
● Express Scripts to cover AbbVie hepatitis C drug, drops Gilead treatment	● 光头Adam Feuerstein关于GILD/ ABBV的最新分析文章
● Gilead Sciences, Inc. Sovaldi Generic Version To Now Sell For $10 In Bangladesh	● Biotech板块的近期走势分析 (转载)
● Gilead will face pressure as too many retailers on board	● 大盘底出来了, biotech可以入场了
● GILD 引起了公愤，搞死了药股	● GILD 今天又跌了，可以捞么？
● GILD 完了	● 会让gild跌吗？

相关话题的讨论汇总
话题: status话题: drugs话题: cvs

进入Stock版参与讨论

1

(共1页)

s******r
发帖数: 868

1

http://www.wsj.com/articles/cvs-gives-preferred-status-to-gilea
ALL IN?

1

(共1页)

进入Stock版参与讨论

相关主题
● 会让gild跌吗？	● Gilead Sciences, Inc. Sovaldi Generic Version To Now Sell For $10 In Bangladesh
● 会让gild跌吗？	● Gilead will face pressure as too many retailers on board
● GILD	● GILD 引起了公愤，搞死了药股
● GILD没戏了	● GILD 完了
● For GILD share holders or anyone of interest	● 200 威逼奖励对GILD的分析
● U.S. FDA approves AbbVie all-oral hepatitis C treatment	● GILD 4:30 ER
● U.S. FDA approves AbbVie all-oral hepatitis C treatment	● Gilead to raise price for new hepatitis C drug above $84,000
● Express Scripts to cover AbbVie hepatitis C drug, drops Gilead treatment	● 光头Adam Feuerstein关于GILD/ ABBV的最新分析文章

相关话题的讨论汇总
话题: status话题: drugs话题: cvs

未名新帖统计// 7月16日

#	版面	帖数(主题数)
-	全站	4871 (796)
1	Military	3777 (569)
2	Stock	341 (51)
3	Joke	117 (17)
4	History	116 (3)
5	Automobile	100 (9)
6	USANews	55 (9)
7	Midlife	45 (1)
8	Headline	41 (41)
9	Dreamer	33 (13)
10	FleaMarket	32 (20)
11	Living	30 (7)

* 这里只显示发帖超过25的版面，努力灌水吧:-)